Elevance Health, Inc. Common Stock (ELV)

The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.

Health insurance provider Elevance Health (NYSEEVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus estimates.

These five stocks with dividend yields already eclipsing that of the overall market just pushed their quarterly dividend payments higher.

On 23 January, Elevance Health (ELV) increased its quarterly dividend by 4.91%, from $1.63 to $1.71 per share. The dividend is payable on 25 March to shareholders of record on 10 March.

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.

Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.

The firm’s medical-loss ratio (MLR) rose to 92.4% due to Medicaid-related costs but was better than expected.

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.

Many stocks flashed buy signals as the major indexes rose to or above key levels.

The Dow giant earnings beat Q4 views, but revenue missed and medical costs ran high.

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's disappointing fourth-quarter 2024 revenue results.

As of Jan. 7, 2025, UnitedHealth Group is the country’s most valuable insurance company, with a market cap of $473 billion.

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.

Discover why HCA Healthcare stock could be poised for a recovery despite recent setbacks, including hurricane-related expenses and claim denials.